Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced a proposed issue of securities, which, subject to ASX approval, may be quoted on a deferred settlement basis. Entities outside Australia issuing a new class of securities must provide an International Securities Identification Number (ISIN), a requirement detailed in the ASX Listing Rules. The company has fulfilled initial lodgement requirements and intends to notify ASX of final security issuance for quotation.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
